Global Top 10 Biotechnology Companies - Industry, Financial and SWOT Analysis
Datamonitor
July 1, 2009 105 Pages - SKU: DFMN2470075
|
|
Countries covered: Global
Scope:
‘Top 10 Global Biotechnology Companies Report: Strategic evaluation of industry and key players’ is a business report that provides a comprehensive view of the global biotechnology industry and its top 10 companies.
The report includes the following:- Industry analysis including market value, market volume, market share and forecast growth till 2012
- Assessment of intensity of competition based on five-forces model including degree of rivalry, substitutes, new entrants, buyer power and supplier power
- SWOT and 5-year financial analysis of top 10 players in the industry
- Descriptive profiles of the leading players including the strategic initiatives undertaken by them in the last 12 months
The top 10 companies have been ascertained based on their global revenues for the financial year 2008.
Highlights:
The global biotechnology market generated total revenues of $171.8 billion in 2007, representing a compound annual growth rate (CAGR) of 10.7% for the period spanning 2003-07. The performance of the market is forecast to decelerate, with an anticipated CAGR of 9.9% for the five-year period 2007-12, which is expected to drive the market to a value of $275.8 billion by the end of 2012.
The top 10 global biotechnology companies recorded revenues of $56.7 billion during 2008, an increase of 12.6% over FY2007. The operating profit of these companies was $15.1 billion in FY2008, an increase of 12.1% over FY2007. The net profit was $10.5 billion during FY2008, an increase of 10.3% over FY2007.
The average operating margin of the top 10 companies was 17% in FY2008 as compared with that of 20.2% in FY2007. The net margin was 10.3% in 2008 as compared with that of 14.9% in 2007.
Since 2003, the global biotechnology market has witnessed a significant growth across different geographies. However, the market growth is expected to decelerate for next few years due to increased number of patent expiries and intensifying competition from biosimilars.
Reasons to Purchase- Gain insights into the industry, leading companies and competitors through a single report
- Benchmark the leading players using 5-year financial analysis, ratios and adjusted financial statement data
- Form opinions about key players using SWOT Analysis to understand internal factors (strengths and weaknesses) and external factors (opportunities and threats) influencing the companies
- Determine industry attractiveness from five-forces analysis of constituent segments.
|
- Executive Summary
- Industry analysis
- Industry definition
- Research highlights
- Top 10 companies landscape
- Market Value
- Market Forecast
- Market Segmentation—Product
- Market Segmentation—Geographic
- Five Forces Analysis
- Summary
- Buyer power
- Supplier power
- New entrants
- Substitutes
- Rivalry
- Top 10 Companies Landscape
- Revenue analysis
- Financial performance analysis
- Company Reports
- Amgen
- Genentech
- Gilead Sciences
- UCB
- Genzyme
- Biogen Idec
- CSL
- Celgene
- Cephalon
- Actelion
- Financial Analysis
- Amgen
- Genentech
- Gilead Sciences
- UCB
- Genzyme
- Biogen Idec
- CSL
- Celgene
- Cephalon
- Actelion
- Appendix
- FIGURES
- Figure 1: Global biotechnology market, $ million, 2003-07
- Figure 2: Global biotechnology market forecast, $ million, 2007-12
- Figure 3: Global biotechnology market segmentation—product, % share, 2007
- Figure 4: Global biotechnology market segmentation—geography, % share, 2007
- Figure 5: Forces driving competition in the global biotechnology market
- Figure 6: Drivers of buyer power in the global biotechnology market
- Figure 7: Drivers of supplier power in the global biotechnology market
- Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology market
- Figure 9: Factors influencing the threat of substitutes in the global biotechnology market
- Figure 10: Drivers of degree of rivalry in the global biotechnology market
- Figure 11: Revenues of global top 10 biotechnology companies, $ million, FY2008
- Figure 12: Revenue growth of global top 10 biotechnology companies, 2006-08
- Figure 13: Operating performance analysis, FY2008
- Figure 14: Net profit analysis, FY2008
- TABLES
- Table 1: Global biotechnology market, $ million, 2003-07
- Table 2: Global biotechnology market forecast, $ million, 2007-12
- Table 3: Global biotechnology market segmentation—product , % share, 2007
- Table 4: Global biotechnology market segmentation—geography, % share, 2007
- Table 5: Revenues of global top 10 biotechnology companies, $ million, FY2008
- Table 6: Revenue growth of global top 10 biotechnology companies, 2006-08
- Table 7: Key financials of global top 10 biotechnology companies, FY2008
- Table 8: Key industry specific ratios, FY2008
- Table 9: Amgen—Financial and operational highlights, 2004-08 ($ million)
- Table 10: Amgen—Key industry specific ratios, 2004-2008
- Table 11: Genentech—Financial and operational highlights, 2004-08 ($ million)
- Table 12: Genentech—Key industry specific ratios, 2004-08
- Table 13: Gilead Sciences—Financial and operational highlights, 2004-08 ($ million)
- Table 14: Gilead Sciences—Key industry specific ratios, 2004-08
- Table 19: UCB—Financial and operational highlights, 2004-08 ($ million)
- Table 20: UCB—Key industry specific ratios, 2004-08
- Table 15: Genzyme—Financial and operational highlights, 2004-08 ($ million)
- Table 16: Genzyme—Key industry specific ratios, 2004-08
- Table 17: Biogen Idec—Financial and operational highlights, 2004-08 ($ million)
- Table 18: Biogen Idec—Key industry specific ratios, 2004-08
- Table 21: CSL—Financial and operational highlights, 2004-08 ($ million)
- Table 22: CSL—Key industry specific ratios, 2004-08
- Table 23: Celgene— Financial and operational highlights, 2004-08 ($ million)
- Table 24: Celgene—Key industry specific ratios, 2004-08
- Table 25: Cephalon—Financial and operational highlights, 2004-2008 ($ million)
- Table 26: Cephalon—Key industry specific ratios, 2004-08
- Table 27: Actelion—Financial and operational highlights, 2004-08 ($ million)
- Table 28: Actelion—Key industry specific ratios, 2004-08
More Global General Biotechnology Reports
Worldwide Biotech - May 2012 by
Worldwide Videotex
WORLDWIDE BIOTECH provides news and information on biotechnology as an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors ...
Global Biotechnology by
IBISWorld
Global Biotechnology Biotechnology is the application of science and technology to living organisms as well as parts, products and models thereof, to alter living or non-living ...
Worldwide Biotech - April 2012 by
Worldwide Videotex
WORLDWIDE BIOTECH provides news and information on biotechnology as an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors ...
Worldwide Biotech - February 2012 by
Worldwide Videotex
Worldwide Biotech provides news and information on
biotechnology as an international industry, reporting on the
deals between U.S. biotechnology companies and international
pharmaceutical corporations. ...
Global Pharmaceuticals, Biotechnology & Life Sciences by
MarketLine
Introduction Global Pharmaceuticals, Biotechnology & Life Sciences industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2006-10, and forecast to ...
See all reports like this >>
Share this report
Other tasks Related Markets General Biotechnology Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
